Skip to main content

Global Bulimia Nervosa Market Statistics Insights by Industry Size, Technology and Trend Analysis 2019 to 2023

The Global Bulimia Nervosa Market Statistics is expected to exhibit significant growth over the forecast period. The market was valued at approximately USD 429.84 million in 2018 and is projected to register a 4.9% CAGR over the forecast period.

Bulimia nervosa is an eating disorder that is characterized by eating a large amount of food (binge eating) in a short period. The disorder is also known as bulimia. Bulimia nervosa may cause various life-threatening and serious complications, such as heart problems, tooth & gum decay, anxiety, self-injury, dehydration, and digestive problems.
Factors such as the rising prevalence of psychological disorders, alcoholism, and diabetes are expected to drive market growth. According to an article published by the National Alliance on Mental Illness (NAMI), 19.1% adults in the US experienced mental illness in 2018. Moreover, drastically changing lifestyle is also expected to boost market growth.
The “Bulimia Nervosa Market Statistics” In-Depth competition analysis of the major companies in the report, sector of the report includes the market depictions, requirements, and product portrayals, manufacture, competence, contact figures, cost, and revenue.
The Bulimia Nervosa Market Statistics provide valuable insight with an emphasis on the global market including some of the major players such As, Allergan, Inc. (Ireland), Eli Lilly and Company (US), AstraZeneca (UK), Bristol-Myers Squibb Company (US), GlaxoSmithKline plc (UK), Pfizer Inc. (US), Johnson & Johnson Services, Inc. (US), Dr. Reddy’s Laboratories Limited (India), Lupin Pharmaceuticals, Inc. (India), Aurobindo Pharma (India), Zydus Cadila (India), Apotex Inc. (Canada), Teva Pharmaceutical Industries Ltd (Israel) and Sun Pharmaceutical Industries Ltd (India)
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region. The competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
Bulimia Nervosa Market Statistics Segment by Regions, regional analysis covers:
  • North America(United States, Canada and Mexico)
  • Europe(Germany, France, UK, Russia and Italy)
  • Asia-Pacific(China, Japan, Korea, India and Southeast Asia)
  • South America(Brazil, Argentina, Colombia etc.)
  • Middle East and Africa(Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Access Complete Detailed TOC Research Report at https://www.marketresearchfuture.com/reports/bulimia-nervosa-market-1417
The report also appraises the supervisory scenarios which affect various decisions in the market. With all the data congregated and scrutinized using SWOT analysis, there is a vibrant picture of the competitive scenario of the Global Bulimia Nervosa Market Statistics.
About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Contact:
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com

Comments

Popular posts from this blog

Healthcare Analytics Market Emerging Trends and Technology Enhancements Research Report 2020

Healthcare Analytics Market Research Report: By Type (Predictive, Cognitive), Component (Software, Services), Delivery Model (On-Premise), Application (Financial Analytics, Clinical Analytics), End User (Payers, Hospitals)- Global Forecast till 2024 Healthcare Analytics Market report offers insights into the leading market players and presents an assessment of their current market position. Company information with regards to revenue, segmental share, geographical income, SWOT, growth strategies, new product launch, M&A activities, and the latest R&D initiatives is also available in the report The report presents a detailed analysis of  Healthcare Analytics Market  by providing readers with a comprehensive overview of the market’s historical trajectory. The leading drivers and restraints affecting the global prostate cancer market are assessed in detail in the report. The historical impact of these drivers and restraints is analyzed in context of the current imp...

3D Sewing Robots Market Technology Development, Growth Strategy, Top Players and Industry Trends with High CAGR by 2026

  3D Sewing Robots Market by Application (Clothes, Footwear, Home DĆ©cor, Bags & Fashion Accessories, Car Interiors, Others) and by Region (Americas [includes both North and South America], Europe, Asia Pacific), Global Trends and Forecast from 2019 to 2026 Global 3D Sewing Robots Market is expected to grow at more than 6.2% CAGR from 2019 to 2026. It is expected to reach above USD 135 million by 2026 from a little above USD 97 million in 2019.  This 3D Sewing Robots market research report discusses the key drivers influencing Automotive & Transportation market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. The Research study also analyses key emerging trends and their impact on present and future development. Major Eminent players making significant moves in the global market have earned their reputation by launching various strategies and profiting:   PFAFF Industriesysteme und Maschinen Gmb...

Krabbe Disease Treatment Market Set to Surge Significantly with New Innovations, Application, Recent Technology

  Krabbe Disease Treatment Market Overview Krabbe disease is an incurable medical condition where the protective coating of nerve cells around the brain are destroyed which causing nerve damage. The global Krabbe disease treatment market can reach a significant valuation, exhibiting a steady CAGR over the forecast period of 2016 to 2022, as per a research report published by Market Research Future (MRFR). The market has been growing continuously on account of increasing incidence of Krabbe disease across the globe. Classification of Krabbe disease under orphan disease has propelled the growth of the market. Pharmaceutical companies receive incentives to develop medicine for rare disease along with reduced fees in protocol assistance and protection from competition after the medicine is marketed. Increased government funding for drug development and easy approvals, tax credits on clinical research, reduction in the amount of registration fees also aid the growth of the market. These...